| Antiretoviral Drugs presently available in the Indian subcontinent. |
|
| Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | Protease Inhibitors (PIs) |
| Zidovudine - 300 mg bid | Nevirapine - 200 mg bid | Indinavir - 800 mg |
| Stavudine - 30-40 mg bid | Efavirenz - 600 mg hs | Nelfinavir - 1250 mg |
| Lamivudine - 150 mg bid | Delavirdine - 400 mg tid | Ritonavir - 600 mg bid |
| Didanosine - 125-200 mg bid | Saquinavir - 1200 mg tid | |
| Zalcitabine - 0.75 mg tid | Amprenavir 1200 mg bid | |
| Abacavir | Lopinavir / Rotinavir 3 cap bid | |
Triple Drug Antiretroviral Regimens combinations available in Indian subcontinent manufactured by Cipla
|
Antiretroviral Drug combinations with Brand names |
|||||
|
2 NRTIs + 1 NNRTI |
No. of Pills / Day | Cost / Month in Rs | |||
| Triomune
- 30 Lamivudine 150mg + Stavudine 30 mg + Nevirapine 200 mg |
|||||
| Triomune
- 40 Lamivudine 150mg + Stavudine 40 mg + Nevirapine 200 mg |
|||||
|
4 |
||||
|
8 |
||||
|
|
|||||||
|
2 NRTIs + 1 PI |
No. of Pills / Day | Cost / Month in Rs | |||||
|
|||||||
|
|||||||
|
8 |
||||||
|
12 |
||||||
Dr. Manbir Singh